Download video

ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors

280 views

Oncology Information Group

7 years ago

ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors

ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors

ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors
2:42
ESMO 2017 - Dr. Brian Rini Updates in Genitourinary Tumors
by Oncology Information Group
Genitourinary cancer highlights at ESMO 2022
1:27
Genitourinary cancer highlights at ESMO 2022
by VJOncology
ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC
4:38
ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC
by GU Oncology Now
#KCRS19: Brian Rini, M D
1:44
#KCRS19: Brian Rini, M D
by KidneyCAN
Update on Treatment Options Brian Rini, M.D.
36:20
Update on Treatment Options Brian Rini, M.D.
by Kidney Cancer
Tips to Help with Brain Health with MS and Neuroimmune Disease
8:40
Tips to Help with Brain Health with MS and Neuroimmune Disease
by Multiple Sclerosis? Even So, It Is Well
MS Prodrome Symptoms - What Are They?!?
8:41
MS Prodrome Symptoms - What Are They?!?
by Multiple Sclerosis? Even So, It Is Well
EVRS 2024 Roundtable: Myopia Traction Maculopathy Treatment | MICE TV
32:04
EVRS 2024 Roundtable: Myopia Traction Maculopathy Treatment | MICE TV
by Media MICE
Dr. Brian Rini Reflects on IKCS Kidney Cancer Meetings
0:37
Dr. Brian Rini Reflects on IKCS Kidney Cancer Meetings
by Kidney Cancer Association
ESMO 2017 - Highlights in RCC - Dr. Sumanta Pal
1:28
ESMO 2017 - Highlights in RCC - Dr. Sumanta Pal
by Oncology Information Group
Genitourinary cancer highlights at ESMO 2023
0:55
Genitourinary cancer highlights at ESMO 2023
by VJOncology
Brian Rini, MD, FASCO, on Why Measuring Patient-Reported Outcomes Is Critical in Oncology Trials
2:55
Brian Rini, MD, FASCO, on Why Measuring Patient-Reported Outcomes Is Critical in Oncology Trials
by CancerNursingToday
Updates in kidney cancer at ESMO 2022
0:59
Updates in kidney cancer at ESMO 2022
by VJOncology
ASCO GU 2020: Dr. Rini Highlights Key Research Efforts in Kidney Cancer
13:35
ASCO GU 2020: Dr. Rini Highlights Key Research Efforts in Kidney Cancer
by OncLive
Metastatic RCC: Mechanisms of Resistance
5:47
Metastatic RCC: Mechanisms of Resistance
by OncLive
The Rationale Behind Combination Therapy in mRCC
3:43
The Rationale Behind Combination Therapy in mRCC
by OncLive
Dr. Rini on Standards of Care for Advanced RCC
0:53
Dr. Rini on Standards of Care for Advanced RCC
by OncLive
The risks of combining therapies in renal cell carcinoma and bladder cancer
1:32
The risks of combining therapies in renal cell carcinoma and bladder cancer
by VJOncology
Drs. Brian Rini and Monty Pal Debate Frontline RCC Treatment Options
5:16
Drs. Brian Rini and Monty Pal Debate Frontline RCC Treatment Options
by GU Oncology Now
Video shots | Highlights and latest updates from ESMO 2024
11:48
Video shots | Highlights and latest updates from ESMO 2024
by Springer Healthcare IME
When No Treatment is the Best Treatment: Observation and Intermittent Strategies Brian I. Rini, M.D.
17:25
When No Treatment is the Best Treatment: Observation and Intermittent Strategies Brian I. Rini, M.D.
by Kidney Cancer
An update on the Phase I trial of BMS-986393, a novel GPRC5D-targeted CAR-T, in R\/R myeloma
1:01
An update on the Phase I trial of BMS-986393, a novel GPRC5D-targeted CAR-T, in R\/R myeloma
by VJHemOnc – Video Journal of Hematology \& HemOnc